A pilot feasibility study to assess a new therapy addresses a critical gap in treatment options for a high-risk patient population with unique emotional needs.
A newly developed prediction model may be able to calculate the risk of opioid relapse among individuals in the early stages of medication treatment—as early as three weeks into therapy.
Health care workers, including registered nurses and support workers, are at increased risk of suicide compared with workers in other fields, Columbia researchers have found.
An event from the Department of Psychiatry and School of Journalism explored the state of mental health in America’s children, adolescents, and young adults.
The post-COVID Community Mental Health Project aims to promote wellness and increase access to behavioral health services in underserved New York City neighborhoods.
A significant level of symptoms of depression, anxiety, and post-traumatic stress may follow COVID-19 independent of any previous psychiatric diagnoses, a new Mailman study finds.
Primary care physicians can help women deal with anxiety and depression, which are on the rise even as COVID cases decline, says Columbia physician Dr. Arthi Reddy.
A Columbia neuroscientist and psychiatrist is peering into brain cells for clues that may explain how COVID-19 can lead to depression, anxiety, psychosis, and suicide.
Specialized psychosocial interventions—including meaning-centered psychotherapy—can greatly improve a cancer patient's quality of life and reduce suffering.
In children with certain autism mutations, the diversity and severity of symptoms are often related to the identity and properties of gene units, called exons, targeted by the mutations.